By rray, 14 June, 2024 These recommendations apply to asymptomatic pts Screen for risk factors w validated risk assessment tools based on FHx 1 3 If screening tool or pt does not meet criteria for high risk then screen as average risk Don t routinely recommend genetic counselin
By rray, 11 June, 2024 Counsel all MSM and transgender women w hx of 1 bacterial STI syphilis chlamydia or gonorrhea in the past 12mo about the benefits and harms of doxycycline PEP 7
By rray, 11 June, 2024 Although not directly assessed in trials doxy PEP could be discussed w MSM and transgender women who haven t been diagnosed w a bacterial STI in the past yr but will engage in sexual activities that uarr likelihood of STI exposure
By rray, 11 June, 2024 Evidence is insufficient in assessing the benefits and harms of doxy PEP in cisgender women cisgender heterosexual men transgender men and other queer and nonbinary persons
By rray, 11 June, 2024 Adverse effects most assoc w doxy include photosensitivity and GI sx including esophageal erosion and ulceration Most ADRs resolve w medication d c
By rray, 11 June, 2024 Perform bacterial STI testing at anatomic sites of exposure at baseline and q3 6mo thereafter